Navigation Links
CardioDynamics Reports 22% Revenue Growth in First Quarter 2008

Fifth Consecutive Quarter of Year Over Year Revenue Growth, Largest in Four


SAN DIEGO, April 10 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq: CDIC), the innovator and leader of Impedance Cardiography (ICG) technology, today reported financial results for fiscal first quarter 2008.

Financial Highlights of First Quarter 2008 Compared with First Quarter 2007
-- Net sales increased 22% to $5.8 million, up from $4.7 million

-- Record $2.3 million international sales, an increase of 364% from

$0.5 million

-- ICG sensor revenue increased 1% to $1,501,000, representing 26% of net

sales, up from $1,488,000, or 31% of sales

-- Operating loss reduced 38% to $852,000, from $1.4 million

-- Cash, equivalents and short-term investments increased to $7.6 million,

up from $3.8 million

Additional Key Operating Milestones for the First Quarter of 2008

-- ICG device sales increased 93% to 266 units, up from a total of

138 units

-- Installed base of BioZ monitors and modules increased 12% to over

8,000 units

-- Carried nearly $1.0 million of order backlog into the second quarter of


-- Field headcount totaled 70 field associates, up from 66 one year ago

-- Entered into distribution and technology license agreements with

Recorders and Medicare Systems, Ltd. (RMS), one of the largest

manufacturers of medical equipment in India.

First Quarter 2008 Operating Results Discussion

The Company reported a net sales increase of 22% to $5.8 million. Sales growth was primarily driven by a 364% increase in international sales and a 14% increase in the average unit sales price of BioZ monitors compared with the first quarter of 2007. The significant growth in international sales during the quarter was the result of the fulfillment of two large hospital customer orders including the Instituto de Salud del Estado de Mexico (ISEM), the hospital network of the state of Mexico within the country of Mexico, and an undisclosed (at the customer's request) eastern European multi-hospital purchaser.

ICG device sales of 266 units included 52 ICG Modules, 214 ICG monitors, 62 of which were BioZ Dx systems, 6 BioZ Monitors, and 146 Medis ICG monitors.

Overall gross margin percentage decreased 5% to 69%, largely due to the non-cash provision of $231,000 of additional reserve for excess, slow moving or obsolete inventory. The additional reserve is primarily driven by lower projected sales of our older model BioZ monitors and the continued success of our BioZ trade-up program.

A 1% reduction in operating expenses was achieved through an 18% decrease in general and administrative expense and 29% reduction in research and development spending during the period, partially offset by increased investment in selling and marketing personnel and programs. The increased revenue and gross margin coupled with reduced operating expenses resulted in an operating loss improvement of 38% to $852,000, from $1.4 million in the same period in 2007. Overall net loss improved by 10%, to $1.5 million, or ($0.03) per diluted share.

CEO Comments and Outlook

"We are very pleased with 22% growth in the first quarter, our best growth quarter in four years," stated Michael K. Perry, Chief Executive Officer of CardioDynamics. "We continued to make good progress in reducing the operating loss, down 38% to $852,000, which includes $242,000 of non-cash charges for depreciation, amortization and equity compensation. We are off to a good start in the second quarter having already shipped the sizeable backlog that resulted from domestic orders booked late in the first quarter. Additionally, we recently increased our U.S. field sales and clinical staff by six additional associates and have hired a dedicated recruiter to assist with our efforts to add talented field personnel. Our sights remain on achieving at least 15% revenue growth for 2008 and delivering positive operating cash flow in the fourth quarter."

Perry added, "We are energized to partner with RMS in India through our previously announced Distribution and Technology License Agreements. RMS has an extensive presence in the developing healthcare market in India, which we believe will be instrumental in helping drive continued market adoption of our proprietary BioZ(R) ICG technology. Additionally, we believe RMS to be a solid technology partner to potentially utilize for low cost development, clinical research and manufacturing."

Conference Call Information

Michael K. Perry, Chief Executive Officer, and Steve P. Loomis, Chief Financial Officer, will host a summary of CardioDynamics' first quarter 2008 results in a conference call today, Thursday April 10, 2008, at 4:30 p.m. (EDT). To access the conference call, dial 800-346-7359 (Code 7784). International participants can call 973-528-0008 (Code 7784). A replay of the call will be available for one month following the call at 800-332-6854 (Code 7784). The international replay number is 973-528-0005 (Code 7784). The Internet webcast can be accessed through the Investor Relations section of the Company's website at or at:

eventDetails&c=86923&eventID=1810586 (Please copy and paste link, and remove extra space after second hyphen.)

About CardioDynamics

CardioDynamics (Nasdaq: CDIC), the ICG Company, is the innovator and leader of an important medical technology called impedance cardiography (ICG). The Company develops, manufactures and markets noninvasive ICG diagnostic and monitoring devices and markets proprietary ICG sensors. The Company's ICG Systems are being used by physicians around the world to help battle the number one killer of men and women -- cardiovascular disease. Partners include GE Healthcare, Philips Medical Systems and Mindray. For additional information, please refer to the company's Web site at

Forward-Looking (Safe Harbor) Statement

Except for historical and factual information contained herein, this press release contains forward-looking statements, such as the success of recruiting efforts and relationship with RMS, anticipated revenue growth rates and cash flow projections, the accuracy of which is necessarily subject to uncertainties and risks including the Company's primary dependence on the BioZ product line, and various uncertainties characteristic of early stage growth companies, as well as other risks detailed in the Company's filings with the SEC, including its 2007 Form 10-K. The Company does not undertake to update the disclosures contained in this press release.

CardioDynamics International Corporation

In thousands, except per share data (unaudited)

Selected Consolidated Three Months Ended

Operational Results February 29, February 28,

2008 2007

Net sales $ 5,762 $ 4,727

Cost of sales 1,775 1,220

Gross margin 3,987 3,507

Research and development 314 443

Selling and marketing 3,722 3,444

General and administrative 771 945

Amortization of intangible assets 32 55

Loss from operations (852) (1,380)

Other expense, net (166) (207)

Loss before income taxes and

minority interest (1,018) (1,587)

Minority interest in income of

subsidiary (134) (14)

Income tax provision (463) (54)

Income (loss) from discontinued

operations, net of tax 127 (7)

Net loss $(1,488) $(1,662)

Net loss per common share:

Basic and diluted $ (0.03) $ (0.03)

Weighted-average shares used in per

share calculation:

Basic and diluted 49,750 48,831

Selected Consolidated Balance February 29, November 30,

Sheet Data 2008 2007

Cash and cash equivalents $ 7,601 $ 8,362

Accounts receivable, net 3,854 4,475

Inventory, net 1,527 1,670

Total current assets 13,586 15,164

Long-term assets 4,708 4,703

Total assets 18,294 19,867

Total current liabilities 5,091 5,620

Long-term liabilities 4,444 4,318

Total liabilities 9,535 9,938

Minority interest 560 407

Shareholders' equity 8,199 9,522

SOURCE CardioDynamics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CardioDynamics Announces Third Quarter 2007 Conference Call and Webcast
2. CardioDynamics Announces Strategic Alliance With Leading Medical Equipment Manufacturer in India
3. CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007
4. CardioDynamics Board of Directors Proposes Reverse Split 1:7 of Companys Shares
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Haemacure Reports Third Quarter 2007 Results
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
11. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... its exceptional customer service: the TrustDale certification. The award recognizes good companies for ... stone honing , tile and grout, and hard surface restoration company earned this ...
(Date:11/24/2015)... ... 24, 2015 , ... Bibliomotion is thrilled to announce the launch ... and Diversity by Nancy M. Schlichting, Chief Executive Officer of Henry Ford ... address the needs of patients and their families, shaped my desire to improve the ...
(Date:11/24/2015)... ... , ... Dr. Kevin Day, local family chiropractor in Warsaw , is ... season. During the Indiana winter months, Vitamin D deficiency can lead to Seasonal ... want to help provide the tools needed to combat it this year! , “Stress ...
(Date:11/24/2015)... ... ... Don Peck’s mother wondered if she was a descendant of Samuel Fuller, a passenger on ... search for information, Don and his aunt discovered that she was not, in fact, related ... was Don’s father who was descended from not one, but four passengers on the famed ...
(Date:11/24/2015)... ... November 24, 2015 , ... World ... Fragrance by Marcelle, a cosmetic invention which offers a combination of natural essential ... in the US is worth $3 billion annually," says Scott Cooper, CEO and ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... F1000Workspace - a research collaboration, reference management and ... six months ago. --> F1000Workspace - a ... since it was launched just six months ago. --> ... F1000Workspace - a research collaboration, reference management and authoring ... months ago. --> --> ...
(Date:11/24/2015)... , Nov. 24, 2015  Family Rentals, ... recently announced the launch of their newly designed, ... --> --> ... --> --> Now, renting ... travel and vacation, just got a whole lot ...
(Date:11/24/2015)... Pa. , Nov. 24, 2015  NuShield, Inc., an industry leader in LCD screen protection ... and stationary computer technology as part of their patient monitoring or electronic documentation system. ... ... ... A ...
Breaking Medicine Technology: